In the next 10 years to see the Biocompatible Materials Market swim in the direction of digitization at a CAGR of 9%

New York, United States, 2022-Apr-11 — /EPR Network/ —

The Biocompatible Materials Market is there to witness a placid CAGR of 9% between 2020 – 2030, reaching US$ 347 Bn. Telehealth has turned out to be a boon – be it with remote monitoring or treating several patients at a distance simultaneously. The time as well stresses on the part of patients and physicians gets saved this way. Virtual follow-up also opens doors for multitasking by the healthcare personnel. This is the present and also would be the future of the healthcare vertical.

Biocompatible materials can be used in dental, orthopaedic, and cardiovascular implants, drug delivery, hearing aids, tissue engineering scaffolds, prosthesis, cosmetics, and other medical devices, as they are easily mouldable, biodegradable, and cost-effective. Biocompatible polymers experience harmless decomposition, which accelerates the healing process in the body. Moreover, manufacturers are focusing on developing their biocompatible portfolios and expanding their application for various diseases such as orthopedic disease and cardiovascular disease.

High prevalence of orthopedic and cardiovascular disorders and technological advancements represent additional opportunities for manufacturers. Hence, increasing investments by companies for advanced product development that are non-toxic and non-immunogenic are also expected to create growth opportunities for the biocompatible materials market. Approval and commercialization of novel biocompatible materials are providing a huge opportunity in developing countries.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/32234

According to a latest report published by Persistence Market Research, the global biocompatible materials market is anticipated to experience a CAGR of over 9% during the forecast period (2020 – 2030).

Companies covered in Biocompatible Materials Market Report

• Dupont
• Ensinger
• Stratasys Ltd.
• Covestro AG
• Foster Corporation
• Merck KGaA
• BASF SE (Exxon Mobil Corporation)
• Wacker Chemie AG
• Celanese Corporation
• Royal DSM
• Evonik Industries AG
• Shin-Etsu Chemical Co. Ltd.
• Henkel AG & Co.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32234

 Key Takeaways from Biocompatible Materials Market Study

• The synthetic polymers segment, under material type, is expected to hold significant revenue share in the biocompatible materials market.
• Surgical & medical instruments are the most attractive applications with the highest share, followed by biocompatible implants. These segments are expected to grow at a higher rate as compared to other applications.
• In terms of regional growth, North America, Europe, and Asia Pacific are manufacturing hubs for biocompatible materials, and are anticipated to witness rapid growth in the global biocompatible materials market.
• The COVID-19 outbreak has created hindrances for the growth of the biocompatible materials market, which will persist in the first half of 2021.

“Upsurge in demand for medical devices and biopharmaceutical products for treatment and diagnosis purposes will boost the global biocompatible materials market over the coming years,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32234

Collaborations & Acquisitions – Key Strategies amongst Market Players

Leading players in the biocompatible materials market are strengthening their product portfolios by launching new products.

• For instance, in June 2020, Ensinger launched Laser direct structuring (LDS): TECACOMP LCP LDS 1049426 black, based on a Liquid Crystal Polymer (LCP).

Various players in the biocompatible materials market are focusing on growth strategies such as expansion, collaborations, and agreement licences.

• In September, 2018, DuPont escalated the manufacturing capacity of the Kinston, North Carolina unit, for elevated production of the bio-based, high-performance DuPont™ Sorona® polymer.
• In May 2019, Stratasys partnered with Solvay for an authorized materials partner program. The partnership will leverage the deposition modelling process of Stratasys with FDM Technology™ in 3D printing applications.
• In October 2020, Covestro acquired the Resins & Functional Materials business (RFM) segment from Royal DSM. The acquisition will strengthen the portfolio of sustainable coating resins.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the biocompatible materials market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2020, on the basis of material type (polymers, metal, ceramic, and composites), application (surgical & medical instruments, implants, drug delivery, and others), end user (medical device manufacturers, academic and research institutes, and biopharmaceutical & pharmaceutical companies), across seven key regions.

About us: Persistence Market Research

Contact us:

Persistence Market Research          
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com